Literature DB >> 35419157

Delayed-Onset Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Following Total Knee Arthroplasty: Case Report.

Megan M J Bauman1,2, Ryan M Naylor1, Ashley R Santilli3, Eelco F Wijdicks3.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a prothrombotic state caused by autoantibodies against platelet factor 4 (PF4)-heparin complexes. Although HIT typically presents 5-10 days after the initiation of heparin, thrombosis and thrombocytopenia may occur up to several weeks following heparin withdrawal, so-called delayed-onset HIT. Although rare, there have been isolated reports of HIT-induced cerebral venous sinus thrombosis (CVST), which carry high rates of morbidity and mortality. There is a need to further characterize the etiology, clinical presentation, treatment paradigms, and outcomes of patients with HIT-induced CVST. Here, we present the case of a 57-year old female who presented to the emergency department with a headache and seizure 11 days following a right total knee arthroplasty for which she received 3 post-operative doses of enoxaparin. Work-up demonstrated acute intracerebral hemorrhage (ICH), CVST, and thrombocytopenia. Intravenous heparin resulted in rapidly deteriorating platelet count and subsequent serologic testing confirmed the diagnosis of HIT. Treatment with bivalirudin was initiated, the HIT resolved, and the patient was discharged home on hospital day 19 with long-term anticoagulation mediated by warfarin. At 3-month follow up, the patient had mild upper motor neuron pattern weakness and was living independently. This case depicts a rare case of delayed-onset HIT and CVST, highlights the importance of establishing a fluid treatment plan for managing HIT-induced CVST, and illustrates the importance of employing rapid anticoagulation despite acute ICH to achieve a desirable clinical outcome.
© The Author(s) 2021.

Entities:  

Keywords:  cerebral venous sinus thrombosis; heparin-induced thrombocytopenia; intracranial hemorrhage; neurocritical care; stroke

Year:  2021        PMID: 35419157      PMCID: PMC8995597          DOI: 10.1177/19418744211042966

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  11 in total

1.  Temporal aspects of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

2.  Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin "flushes".

Authors:  Majed A Refaai; Theodore E Warkentin; Michael Axelson; Karen Matevosyan; Ravindra Sarode
Journal:  Thromb Haemost       Date:  2007-11       Impact factor: 5.249

3.  Delayed-onset heparin-induced thrombocytopenia.

Authors:  Lawrence Rice; Walid K Attisha; Alane Drexler; John L Francis
Journal:  Ann Intern Med       Date:  2002-02-05       Impact factor: 25.391

4.  Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder.

Authors:  Theodore E Warkentin; Paul A Basciano; Jared Knopman; Richard A Bernstein
Journal:  Blood       Date:  2014-03-27       Impact factor: 22.113

5.  The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital.

Authors:  Maureen A Smythe; John M Koerber; Joan C Mattson
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

6.  Autoimmune heparin-induced thrombocytopenia of delayed onset: a clinical challenge.

Authors:  Anne Kuitunen; Marjatta Sinisalo; Annukka Vahtera; Leena Hiltunen; Kaija Javela; Outi Laine
Journal:  Transfusion       Date:  2018-10-04       Impact factor: 3.157

Review 7.  Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.

Authors:  Dilli Ram Poudel; Sushil Ghimire; Rashmi Dhital; Daniel A Forman; Theodore E Warkentin
Journal:  Platelets       Date:  2017-08-31       Impact factor: 3.862

8.  Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan.

Authors:  A Greinacher; I Michels; M Schäfer; V Kiefel; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1992-06       Impact factor: 6.998

9.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

10.  Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty.

Authors:  Steven R Hwang; Yuxiang Wang; Erika L Weil; Anand Padmanabhan; Theodore E Warkentin; Rajiv K Pruthi
Journal:  Platelets       Date:  2020-10-01       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.